Top Markets
Coin of the day
Stella Pharma Corporation Stella Pharma Corporation

Stella Pharma Corporation

4888
Rank in Stocks #22897
Stella Pharma Corporation is a pharmaceutical company that handles the complete... Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
Share Price
$2.26
Last synced: 2026-08-21
Market Cap
$81.55M
Change (1 day)
-0.86%
Change (1 year)
-18.45%
Country
JP
Trade Stella Pharma Corporation (4888)

Category

P/B ratio for Stella Pharma Corporation (4888)
P/B ratio as of 2026 TTM: 0
According to Stella Pharma Corporation latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Stella Pharma Corporation from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH